NeuroBo Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on NeuroBo Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date NeuroBo Pharmaceuticals Inc Strategy Report
- Understand NeuroBo Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on NeuroBo Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AR122015A1 | Application | FORMULACIONES DE NICLOSAMIDA Y MÉTODOS DE USO | August 03, 2022 | |
| WO2022147499A1 | Application | METHOD OF TREATING VIRAL INFECTIONS WITH A COMBINATION OF NICLOSAMIDE AND GEMCABENE | A61K31/194; A61K31/609; A61P31/12; A61P31/14 | July 07, 2022 |
| EP3867222A4 | Search Report | GEMCABEN, PHARMAZEUTISCH UNBEDENKLICHE SALZE DAVON, ZUSAMMENSETZUNGEN DAVON UND VERFAHREN ZUR VERWENDUNG DAVON | A61K31/194; A61K9/0053; A61K9/2009; A61K9/2013; A61K9/2018; A61K9/2054; A61K9/2059; A61K9/2063; A61K9/28; A61K9/2866; A61P1/16; A61P1/18; A61P11/00; A61P21/00; A61P9/00; A61P9/10; C07B2200/13; C07C69/708 | July 06, 2022 |
| HUE056404T2 | Application | COMPOSITION CONTAINING PORIA COCOS BARK EXTRACT FOR PREVENTING, IMPROVING OR TREATING NEURODEGENERATIVE DISORDERS | A61K9/00; A61P25/00; A23V2002/00; A61P25/16; A61K36/076; A61P25/28 | February 28, 2022 |
| US20220031642A1 | Application | Niclosamide Formulations and Methods of Use | A61K31/167; A61K9/16; A61K9/485; A61K9/4858; A61K9/4866; A61P31/14 | February 03, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer